FDA 510(k)

Access 乙型肝炎核心抗体IgM

K号: K254059 · 2026-03-13

决定日期2026-03-13

产品代码SEI

咨询委员会抱歉，您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

Access anti-HBc IgM is the device name listed in this FDA 510(k) record. The listed applicant is Beckman Coulter, Inc.. It received FDA 510(k) clearance on 2026-03-13 under 510(k) number K254059. The device is classified under product code SEI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Access anti-HBc IgM?

Access anti-HBc IgM is a medical device that received FDA 510(k) clearance on 2026-03-13. The listed applicant is Beckman Coulter, Inc.. The 510(k) number is K254059.

When did Access anti-HBc IgM receive FDA 510(k) clearance?

Access anti-HBc IgM received FDA 510(k) clearance on 2026-03-13, under 510(k) number K254059.

Who is the listed applicant for Access anti-HBc IgM?

FDA 510(k)记录中列出Beckman Coulter, Inc.为申请人。这本身并不能确立该设备制造商的身份。

What is the FDA product code for Access anti-HBc IgM?

The FDA product code for Access anti-HBc IgM is SEI.

列明Beckman Coulter, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K262109Access NT-proBNP K252169Access BNP II K253687Access 乙型肝炎核心抗体总抗体 K251995Access 乙型肝炎核心抗体IgM K250588Access 风疹IgG K252580iQ200系列

查看所有 73 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。